Correlation Between Satsuma Pharmaceuticals and Codiak BioSciences

Can any of the company-specific risk be diversified away by investing in both Satsuma Pharmaceuticals and Codiak BioSciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Satsuma Pharmaceuticals and Codiak BioSciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Satsuma Pharmaceuticals and Codiak BioSciences, you can compare the effects of market volatilities on Satsuma Pharmaceuticals and Codiak BioSciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Satsuma Pharmaceuticals with a short position of Codiak BioSciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Satsuma Pharmaceuticals and Codiak BioSciences.

Diversification Opportunities for Satsuma Pharmaceuticals and Codiak BioSciences

0.0

Correlation Coefficient

Satsuma Pharmaceuticals  Codiak BioSciences

Pay attention - limited upside

The 3 months correlation between Satsuma and Codiak is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Satsuma Pharmaceuticals and Codiak BioSciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Codiak BioSciences and Satsuma Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Satsuma Pharmaceuticals are associated (or correlated) with Codiak BioSciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Codiak BioSciences has no effect on the direction of Satsuma Pharmaceuticals i.e., Satsuma Pharmaceuticals and Codiak BioSciences go up and down completely randomly.

Pair Corralation between Satsuma Pharmaceuticals and Codiak BioSciences

If you would invest  83.00  in Satsuma Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of  27.00  from holding Satsuma Pharmaceuticals or generate 32.53% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Satsuma Pharmaceuticals  vs.  Codiak BioSciences

Satsuma Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Satsuma Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Satsuma Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Codiak BioSciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Codiak BioSciences has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable forward-looking signals, Codiak BioSciences is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Satsuma Pharmaceuticals and Codiak BioSciences

The main advantage of trading using opposite Satsuma Pharmaceuticals and Codiak BioSciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Satsuma Pharmaceuticals position performs unexpectedly, Codiak BioSciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Codiak BioSciences will offset losses from the drop in Codiak BioSciences' long position.

The idea behind Satsuma Pharmaceuticals and Codiak BioSciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.